Adjunctive Psychotherapy for Perinatal Bipolar Disorder


Bipolar disorder (BD) is a serious, disabling, and highly recurrent illness. The perinatal period dramatically increases risk for mood episodes in women with BD, but pregnancy complicates pharmacologic treatment decisions and efficacy. This study will be the first to systematically develop and pilot test an adjunctive psychosocial intervention to assist in treatment of BD during the high-risk perinatal period.

Study Start Date

April 2014

Estimated Completion Date

March 2017


  • Behavioral: Enhanced Treatment as Usual
  • Behavioral: Interpersonal and Social Rhythm Therapy


  • Nursing: Mental Health
  • Psychiatry: Mood Disorders
  • Family Medicine: Psychiatry

MeSH Terms

  • Bipolar Disorder

Study ID

Brown University -- 1 R34 MH102466-01A1



Trial ID


Study Type


Trial Phase


Enrollment Quota



Brown University

Inclusion Criteria

  • DSM-5 diagnosis of bipolar I or bipolar II disorder
  • at least moderately symptomatic (depression or manic symptoms) at time of study entry
  • currently pregnant, up to 28 weeks gestation

Exclusion Criteria

  • presence of psychiatric symptoms severe enough to warrant inpatient hospitalization
  • current psychotic symptoms
  • active alcohol or substance use disorder
  • cognitive deficits that preclude full understanding of study materials
  • inability to understand English sufficiently well to understand consent or assessment instruments when read aloud
  • plans to relocate within 8 months




18 Years and older

Accepts Healthy Volunteers


Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Butler Hospital - Providence, Rhode Island 39.6 miles Lauren M Weinstock PhD 401-455-6304 provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.